Marvelon
ApprovedUNKNOWN 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Menstrual Problem
Conditions
Menstrual Problem
Trial Timeline
Jul 1, 2011 → Apr 1, 2013
NCT ID
NCT01384331About Marvelon
Marvelon is a approved stage product being developed by Merck for Menstrual Problem. The current trial status is unknown. This product is registered under clinical trial identifier NCT01384331. Target conditions include Menstrual Problem.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01384331 | Approved | UNKNOWN |
Competing Products
11 competing products in Menstrual Problem
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Elagolix + Estradiol /norethindrone acetate (E2/NETA) | AbbVie | Phase 3 | 77 |
| Atogepant + Placebo for Atogepant | AbbVie | Phase 3 | 77 |
| paroxetine | Novo Nordisk | Approved | 84 |
| Levonorgestrel/Ethinyl Estradiol | Pfizer | Phase 3 | 76 |
| Rimegepant + Placebo Comparator + Standard of Care + Rimegepant | Pfizer | Phase 3 | 76 |
| Levonorgestrel/Ethinyl Estradiol | Pfizer | Phase 3 | 76 |
| Levetiracetam | UCB | Pre-clinical | 20 |
| Drospirenone and ethinyl estradiol + Placebo | Bayer | Pre-clinical | 20 |
| EE20/DRSP(YAZ, BAY86-5300) + Placebo | Bayer | Phase 3 | 74 |
| Vilaprisan (BAY1002670) | Bayer | Phase 3 | 74 |
| Etonogestrel 68mg implant | Organon | Phase 1 | 28 |